Rights and Permissions
Mark W Tenforde, Wesley H Self, Yuwei Zhu, Eric A Naioti, Manjusha Gaglani, Adit A Ginde, Kelly Jensen, H Keipp Talbot, Jonathan D Casey, Nicholas M Mohr, Anne Zepeski, Tresa McNeal, Shekhar Ghamande, Kevin W Gibbs, D Clark Files, David N Hager, Arber Shehu, Matthew E Prekker, Heidi L Erickson, Michelle N Gong, Amira Mohamed, Nicholas J Johnson, Vasisht Srinivasan, Jay S Steingrub, Ithan D Peltan, Samuel M Brown, Emily T Martin, Arnold S Monto, Akram Khan, Catherine L Hough, Laurence W Busse, Caitlin ten Lohuis, Abhijit Duggal, Jennifer G Wilson, Nida Qadir, Steven Y Chang, Christopher Mallow, Carolina Rivas, Hilary M Babcock, Jennie H Kwon, Matthew C Exline, Mena M Botros, Adam S Lauring, Nathan I Shapiro, Natasha Halasa, James D Chappell, Carlos G Grijalva, Todd W Rice, Ian D Jones, William B Stubblefield, Adrienne Baughman, Kelsey N Womack, Jillian P Rhoads, Christopher J Lindsell, Kimberly W Hart, Caitlin Turbyfill, Samantha Olson, Nancy Murray, Katherine Adams, Manish M Patel, for the Influenza and Other Viruses in the Acutely Ill (IVY) Network, Protection of Messenger RNA Vaccines Against Hospitalized Coronavirus Disease 2019 in Adults Over the First Year Following Authorization in the United States, Clinical Infectious Diseases, Volume 76, Issue 3, 1 February 2023, Pages e460–e468, https://doi.org/10.1093/cid/ciac381. https://academic.oup.com/cid/article/76/3/e460/6587132?login=true. Published by Oxford University Press on behalf of the Infectious Diseases Society of America 2022.
This work is written by (a) US Government employee(s) and is in the public domain in the US.